Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant

Immunopharmacology

Volumn 46, Issue 1, 2000, Pages 29-37

  Azuma, Takayoshi ^a   Watanabe, Naoko ^a   Yagisawa, Hitoshi ^b   Hirata, Hajime ^b   Iwamura, Michiko ^a   Kobayashi, Yoshiro ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

Author keywords

Apoptosis; Cell type specificity; Cycloprodigiosin; Immunosuppressant

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYCLOPRODIGIOSIN; DNA FRAGMENT; IMMUNOSUPPRESSIVE AGENT; LEUCYLLEUCINE METHYL ESTER; LIPOPOLYSACCHARIDE; PLANT LECTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CONCANAVALIN A; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; INDOLES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PYRROLES; SPLEEN; T-LYMPHOCYTES;

EID: 0033985810     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00153-8     Document Type: Article

References (19)

1. Canadian Multicenter Transplant Study Group A randomized clinical trial of cyclosporin in cadaveric renal transplantation. N. Engl. J. Med. 314:1986;1219-1229.
2. Enosawa S., Suzuki S., Kakefuda T., Li X.K., Amemiya H. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology. 34:1996;171-179.
3. Julius M.H., Simpson E., Herzenberg R.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:1973;645-649.
4. Kataoka T., Magae J., Nariuchi H., Yamasaki M., Nagai K. Enhancement by concanavalin A of the suppressive effect of prodigiosin 25-C on proliferation of murine splenocytes. J. Antibiot. 45:1992;1303-1311.
5. Kataoka T., Muroi M., Ohkuma S., Ohkuma S., Waritani T., Magae J., Takatsuki A., Kondo S., Yamasaki M., Nagai K. Prodigiosin 25-C uncouples vacuolar type H+-ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS Lett. 359:1995;53-59.
6. Kawauchi K., Shibutani K., Yagisawa H., Kamata H., Nakatsuji S., Anzai H., Yokoyama Y., Ikegami Y., Moriyama Y., Hirata H. A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans. Biochem. Biophys. Res. Commun. 237:1997;543-547.
7. Liu J. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today. 14:1993;290-295.
8. Migita K., Eguchi K., Kawabe Y., Tsukada T., Mizokami A., Nagataki S. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J. Clin. Invest. 96:1995;727-732.
9. Nakamura A., Magae J., Tsuji R.F., Yamasaki M., Nagai K. Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation. 47:1989;1013-1016.
10. Nakano T., Imai Y., Naiki M., Osawa T. Characterization of mouse helper and suppressor cell subsets separated by lectins. J. Immunol. 125:1980;1928-1932.
11. Poetschke H.L., Klug D.B., Walker D., Richie E.R. Cross-linking the TCR complex induces apoptosis in CD4+8+ thymocytes in the presence of cyclosporin A. Dev. Immunol. 5:1996;1-15.
12. Sigal N.H., Dumont F.J. Cyclosporin A, FK506 and rapamycin; pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:1992;519-560.
13. Songia S., Mortellaro A., Taverna S., Fornasiero C., Scheiber E.A., Erba E., Colotta F., Mantovani A., Isetta A.-M., Golay J. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes. J. Immunol. 158:1997;3987-3995.
14. Suzuki S., Enosawa S., Kakefuda T., Shinomiya T., Amari M., Naoe S., Hoshino Y., Chiba K. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acception in rat and dog allotransplantation. Transplantation. 61:1996;200-205.
15. Thiele D.L., Lipsky P.E. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J. Immunol. 136:1986;1038-1047.
16. Thiele D.L., Lipsky P.E. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc. Natl. Acad. Sci. U.S.A. 87:1990;83-87.
17. Thiele D.L., Lipsky P.E. Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester. J. Immunol. 148:1992;3950-3957.
18. Van den Steel P., Rudd P.M., Dwek R.A., Van Damme J., Opdenakker G. Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity. Adv. Exp. Med. Biol. 435:1998;133-143.
19. Watanabe N., Kawaguchi M., Kobayashi Y. Activation of interleukin-1β-converting enzyme by nigericin is independent of apoptosis. Cytokine. 10:1998;645-653.